A fast, 7-day Gel Treatment against Varroa, effective without Temperature Constraints during Use
After several years of intensive R&D work, Véto-pharma obtained a registration for an innovative amitraz gel formulation specially tailored to meet the needs of commercial beekeepers: a 7-day-flash treatment packaged to reduce labor costs, highly versatile as it can be used in-between honey flows, temperature independent during use, without withdrawal period and delivering controlled and accurate dosing via a specially designed dosing gun.
We are pleased to announce that Amiflex has recently been registered in Canada. The product is the same as in the USA, and the formulation and packaging of Amiflex in Canada and Amiflex 2.0 in the United States are identical. The only differences are the product name – used for registration purposes – and the maximum number of applications allowed per year.
An Amitraz Treatment without Temperature Constraints during Use
Amiflex / Amiflex 2.0 is an innovative varroa mite treatment based on amitraz. It is the result of 6 years of R&D by the Véto-pharma team. The goal was to provide a legal, safe and ready-to-use “flash” amitraz product for commercial beekeepers. Challenge accepted!
The Amiflex / Amiflex 2.0 gel provides an easy way to treat hives before, between or after honey flows, or just before starting a slow-release treatment, without temperature constraints.1
With its gel formulation and contact delivery system, Amiflex delivers a rapid kock-down effects, reducing varroa mite populations.
Amiflex® / Amiflex® 2.0: Available in the USA and Canada
Product details and information are tailored to each country to meet local regulatory requirements.
To access the appropriate webpage, please select your country below.
More information and detailed content about the Amiflex / Amiflex 2.0 US version: user instructions, FAQs, downloadable resources, distributors, and more.
More information and detailed content about the Amiflex Canadian version: user instructions, FAQs, downloadable resources, distributors, and more.
1 – No temperature constraints during the treatment.
AFX-22-IN-N01-12/25